Table2.
The result of established method was validated in cell lines
| Cell line | ATCC previously reported | Result of established method |
| H460 | KRAS mutation PIK3CA mutation | KRAS_Q61H (c.183A>T) PIK3CA_E545K (c.1633G>A ) |
| PC9 | EGFR_ Exon19 deletion | p.E746_A750delELREA (c.2235-2249del15) |
| H1650 | EGFR_ Exon19 deletion | p.E746_A750delELREA (c.2235-2249del15) |
| H1975 | EGFR_L858R EGFR_T790M | EGFR_L858R (c.2573T>G) EGFR_T790M (c.2369C>T) |
| A549 | KRAS mutation | KRAS_G12S (c.34G>A) |
| GLC82 | EGFR_L858R | EGFR_L858R (c.2573_2574TG>GT) |
| HCC827 | EGFR Exon19 deletion | p.E746_A750delELREA (c.2236_2250del15) |
| H1299 | EGFR/ALK/KRAS negative | No mutation |